Microwave assisted synthesis of novel acridine–acetazolamide conjugates and investigation of their inhibition effects on human carbonic anhydrase isoforms hCA I, II, IV and VII
[Display omitted] 4-Amino-N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)benzamide was condensed with cyclic-1,3-diketones (dimedone and cyclohexane-1,3-dione) and aromatic aldehydes under microwave irradiation, leading to a series of acridine–acetazolamide conjugates. The new compounds were investigated as i...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry 2016-08, Vol.24 (16), p.3548-3555 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3555 |
---|---|
container_issue | 16 |
container_start_page | 3548 |
container_title | Bioorganic & medicinal chemistry |
container_volume | 24 |
creator | Ulus, Ramazan Aday, Burak Tanç, Muhammet Supuran, Claudiu T. Kaya, Muharrem |
description | [Display omitted]
4-Amino-N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)benzamide was condensed with cyclic-1,3-diketones (dimedone and cyclohexane-1,3-dione) and aromatic aldehydes under microwave irradiation, leading to a series of acridine–acetazolamide conjugates. The new compounds were investigated as inhibitors of carbonic anhydrases (CA, EC 4.2.1.1), and more precisely cytosolic isoforms hCA I, II, VII and membrane-bound one hCA IV. All investigated isoforms were inhibited in low micromolar and nanomolar range by the new compounds. hCA IV and VII were inhibited with KIs in the range of 29.7–708.8nM (hCA IV), and of 1.3–90.7nM (hCA VII). For hCA I and II the KIs were in the range of 6.7–335.2nM (hCA I) and of 0.5–55.4nM (hCA II). The structure–activity relationships (SAR) for the inhibition of these isoforms with the acridine–acetazolamide conjugates reported here were delineated. |
doi_str_mv | 10.1016/j.bmc.2016.05.064 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1805766698</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0968089616304084</els_id><sourcerecordid>1805766698</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-a363f4314a9e0909598e0ed4dd9e2eaf9538d6dee11e91a9792b54f053b1adf93</originalsourceid><addsrcrecordid>eNp9UcFu1DAQtRCILoUP4IJ85ECCHSfeWJyqFS2RirhAr5Zjj4lXiV3sZKvtqf_QP-kn8SV4u4Ujh5HHT--90cxD6C0lJSWUf9yW_aTLKrclaUrC62doRWteF4wJ-hytiOBtQVrBT9CrlLaEkKoW9CU6qdaVaAlpVujhq9Mx3KgdYJWSSzMYnPZ-HiB_cLDYhx2MWOnojPPw--5eaZjVbRjV5AxgHfx2-almSFh5g53fQZpdBlzwB3k2cjHDg-vdIwbWgp6ztcfDMimPtYp98E5n_bA3USXALgUb4pTwsDnD3QfcHerqccBV171GL6waE7x5ek_Rj_PP3zdfistvF93m7LLQrGFzoRhntma0VgKIIKIRLRAwtTECKlBWNKw13ABQCoIqsRZV39SWNKynyljBTtH7o-91DL-WvJacXNIwjspDWJKkLWnWnHPRZio9UvMtU4pg5XV0k4p7SYk8RCW3MkclD1FJ0sgcVda8e7Jf-gnMP8XfbDLh05EAecmdgyiTduA1GBfzCaUJ7j_2fwCZKqiT</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1805766698</pqid></control><display><type>article</type><title>Microwave assisted synthesis of novel acridine–acetazolamide conjugates and investigation of their inhibition effects on human carbonic anhydrase isoforms hCA I, II, IV and VII</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Ulus, Ramazan ; Aday, Burak ; Tanç, Muhammet ; Supuran, Claudiu T. ; Kaya, Muharrem</creator><creatorcontrib>Ulus, Ramazan ; Aday, Burak ; Tanç, Muhammet ; Supuran, Claudiu T. ; Kaya, Muharrem</creatorcontrib><description>[Display omitted]
4-Amino-N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)benzamide was condensed with cyclic-1,3-diketones (dimedone and cyclohexane-1,3-dione) and aromatic aldehydes under microwave irradiation, leading to a series of acridine–acetazolamide conjugates. The new compounds were investigated as inhibitors of carbonic anhydrases (CA, EC 4.2.1.1), and more precisely cytosolic isoforms hCA I, II, VII and membrane-bound one hCA IV. All investigated isoforms were inhibited in low micromolar and nanomolar range by the new compounds. hCA IV and VII were inhibited with KIs in the range of 29.7–708.8nM (hCA IV), and of 1.3–90.7nM (hCA VII). For hCA I and II the KIs were in the range of 6.7–335.2nM (hCA I) and of 0.5–55.4nM (hCA II). The structure–activity relationships (SAR) for the inhibition of these isoforms with the acridine–acetazolamide conjugates reported here were delineated.</description><identifier>ISSN: 0968-0896</identifier><identifier>EISSN: 1464-3391</identifier><identifier>DOI: 10.1016/j.bmc.2016.05.064</identifier><identifier>PMID: 27298005</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Acetazolamide ; Acetazolamide - chemistry ; Acetazolamide - pharmacology ; Acridine ; Carbonic anhydrase ; Carbonic Anhydrase Inhibitors - chemistry ; Carbonic Anhydrase Inhibitors - pharmacology ; Enzyme inhibition ; Humans ; Isoenzymes - drug effects ; Isoforms CA I, II, IV and VII ; Microwaves ; Spectrum Analysis - methods</subject><ispartof>Bioorganic & medicinal chemistry, 2016-08, Vol.24 (16), p.3548-3555</ispartof><rights>2016 Elsevier Ltd</rights><rights>Copyright © 2016 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-a363f4314a9e0909598e0ed4dd9e2eaf9538d6dee11e91a9792b54f053b1adf93</citedby><cites>FETCH-LOGICAL-c353t-a363f4314a9e0909598e0ed4dd9e2eaf9538d6dee11e91a9792b54f053b1adf93</cites><orcidid>0000-0002-1031-5941 ; 0000-0003-4262-0323</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0968089616304084$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27298005$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ulus, Ramazan</creatorcontrib><creatorcontrib>Aday, Burak</creatorcontrib><creatorcontrib>Tanç, Muhammet</creatorcontrib><creatorcontrib>Supuran, Claudiu T.</creatorcontrib><creatorcontrib>Kaya, Muharrem</creatorcontrib><title>Microwave assisted synthesis of novel acridine–acetazolamide conjugates and investigation of their inhibition effects on human carbonic anhydrase isoforms hCA I, II, IV and VII</title><title>Bioorganic & medicinal chemistry</title><addtitle>Bioorg Med Chem</addtitle><description>[Display omitted]
4-Amino-N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)benzamide was condensed with cyclic-1,3-diketones (dimedone and cyclohexane-1,3-dione) and aromatic aldehydes under microwave irradiation, leading to a series of acridine–acetazolamide conjugates. The new compounds were investigated as inhibitors of carbonic anhydrases (CA, EC 4.2.1.1), and more precisely cytosolic isoforms hCA I, II, VII and membrane-bound one hCA IV. All investigated isoforms were inhibited in low micromolar and nanomolar range by the new compounds. hCA IV and VII were inhibited with KIs in the range of 29.7–708.8nM (hCA IV), and of 1.3–90.7nM (hCA VII). For hCA I and II the KIs were in the range of 6.7–335.2nM (hCA I) and of 0.5–55.4nM (hCA II). The structure–activity relationships (SAR) for the inhibition of these isoforms with the acridine–acetazolamide conjugates reported here were delineated.</description><subject>Acetazolamide</subject><subject>Acetazolamide - chemistry</subject><subject>Acetazolamide - pharmacology</subject><subject>Acridine</subject><subject>Carbonic anhydrase</subject><subject>Carbonic Anhydrase Inhibitors - chemistry</subject><subject>Carbonic Anhydrase Inhibitors - pharmacology</subject><subject>Enzyme inhibition</subject><subject>Humans</subject><subject>Isoenzymes - drug effects</subject><subject>Isoforms CA I, II, IV and VII</subject><subject>Microwaves</subject><subject>Spectrum Analysis - methods</subject><issn>0968-0896</issn><issn>1464-3391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UcFu1DAQtRCILoUP4IJ85ECCHSfeWJyqFS2RirhAr5Zjj4lXiV3sZKvtqf_QP-kn8SV4u4Ujh5HHT--90cxD6C0lJSWUf9yW_aTLKrclaUrC62doRWteF4wJ-hytiOBtQVrBT9CrlLaEkKoW9CU6qdaVaAlpVujhq9Mx3KgdYJWSSzMYnPZ-HiB_cLDYhx2MWOnojPPw--5eaZjVbRjV5AxgHfx2-almSFh5g53fQZpdBlzwB3k2cjHDg-vdIwbWgp6ztcfDMimPtYp98E5n_bA3USXALgUb4pTwsDnD3QfcHerqccBV171GL6waE7x5ek_Rj_PP3zdfistvF93m7LLQrGFzoRhntma0VgKIIKIRLRAwtTECKlBWNKw13ABQCoIqsRZV39SWNKynyljBTtH7o-91DL-WvJacXNIwjspDWJKkLWnWnHPRZio9UvMtU4pg5XV0k4p7SYk8RCW3MkclD1FJ0sgcVda8e7Jf-gnMP8XfbDLh05EAecmdgyiTduA1GBfzCaUJ7j_2fwCZKqiT</recordid><startdate>20160815</startdate><enddate>20160815</enddate><creator>Ulus, Ramazan</creator><creator>Aday, Burak</creator><creator>Tanç, Muhammet</creator><creator>Supuran, Claudiu T.</creator><creator>Kaya, Muharrem</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1031-5941</orcidid><orcidid>https://orcid.org/0000-0003-4262-0323</orcidid></search><sort><creationdate>20160815</creationdate><title>Microwave assisted synthesis of novel acridine–acetazolamide conjugates and investigation of their inhibition effects on human carbonic anhydrase isoforms hCA I, II, IV and VII</title><author>Ulus, Ramazan ; Aday, Burak ; Tanç, Muhammet ; Supuran, Claudiu T. ; Kaya, Muharrem</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-a363f4314a9e0909598e0ed4dd9e2eaf9538d6dee11e91a9792b54f053b1adf93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Acetazolamide</topic><topic>Acetazolamide - chemistry</topic><topic>Acetazolamide - pharmacology</topic><topic>Acridine</topic><topic>Carbonic anhydrase</topic><topic>Carbonic Anhydrase Inhibitors - chemistry</topic><topic>Carbonic Anhydrase Inhibitors - pharmacology</topic><topic>Enzyme inhibition</topic><topic>Humans</topic><topic>Isoenzymes - drug effects</topic><topic>Isoforms CA I, II, IV and VII</topic><topic>Microwaves</topic><topic>Spectrum Analysis - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ulus, Ramazan</creatorcontrib><creatorcontrib>Aday, Burak</creatorcontrib><creatorcontrib>Tanç, Muhammet</creatorcontrib><creatorcontrib>Supuran, Claudiu T.</creatorcontrib><creatorcontrib>Kaya, Muharrem</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic & medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ulus, Ramazan</au><au>Aday, Burak</au><au>Tanç, Muhammet</au><au>Supuran, Claudiu T.</au><au>Kaya, Muharrem</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Microwave assisted synthesis of novel acridine–acetazolamide conjugates and investigation of their inhibition effects on human carbonic anhydrase isoforms hCA I, II, IV and VII</atitle><jtitle>Bioorganic & medicinal chemistry</jtitle><addtitle>Bioorg Med Chem</addtitle><date>2016-08-15</date><risdate>2016</risdate><volume>24</volume><issue>16</issue><spage>3548</spage><epage>3555</epage><pages>3548-3555</pages><issn>0968-0896</issn><eissn>1464-3391</eissn><abstract>[Display omitted]
4-Amino-N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)benzamide was condensed with cyclic-1,3-diketones (dimedone and cyclohexane-1,3-dione) and aromatic aldehydes under microwave irradiation, leading to a series of acridine–acetazolamide conjugates. The new compounds were investigated as inhibitors of carbonic anhydrases (CA, EC 4.2.1.1), and more precisely cytosolic isoforms hCA I, II, VII and membrane-bound one hCA IV. All investigated isoforms were inhibited in low micromolar and nanomolar range by the new compounds. hCA IV and VII were inhibited with KIs in the range of 29.7–708.8nM (hCA IV), and of 1.3–90.7nM (hCA VII). For hCA I and II the KIs were in the range of 6.7–335.2nM (hCA I) and of 0.5–55.4nM (hCA II). The structure–activity relationships (SAR) for the inhibition of these isoforms with the acridine–acetazolamide conjugates reported here were delineated.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>27298005</pmid><doi>10.1016/j.bmc.2016.05.064</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-1031-5941</orcidid><orcidid>https://orcid.org/0000-0003-4262-0323</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0968-0896 |
ispartof | Bioorganic & medicinal chemistry, 2016-08, Vol.24 (16), p.3548-3555 |
issn | 0968-0896 1464-3391 |
language | eng |
recordid | cdi_proquest_miscellaneous_1805766698 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Acetazolamide Acetazolamide - chemistry Acetazolamide - pharmacology Acridine Carbonic anhydrase Carbonic Anhydrase Inhibitors - chemistry Carbonic Anhydrase Inhibitors - pharmacology Enzyme inhibition Humans Isoenzymes - drug effects Isoforms CA I, II, IV and VII Microwaves Spectrum Analysis - methods |
title | Microwave assisted synthesis of novel acridine–acetazolamide conjugates and investigation of their inhibition effects on human carbonic anhydrase isoforms hCA I, II, IV and VII |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T16%3A15%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Microwave%20assisted%20synthesis%20of%20novel%20acridine%E2%80%93acetazolamide%20conjugates%20and%20investigation%20of%20their%20inhibition%20effects%20on%20human%20carbonic%20anhydrase%20isoforms%20hCA%20I,%20II,%20IV%20and%20VII&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry&rft.au=Ulus,%20Ramazan&rft.date=2016-08-15&rft.volume=24&rft.issue=16&rft.spage=3548&rft.epage=3555&rft.pages=3548-3555&rft.issn=0968-0896&rft.eissn=1464-3391&rft_id=info:doi/10.1016/j.bmc.2016.05.064&rft_dat=%3Cproquest_cross%3E1805766698%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1805766698&rft_id=info:pmid/27298005&rft_els_id=S0968089616304084&rfr_iscdi=true |